Literature DB >> 11846225

Defense against influenza A virus infection: essential role of the chemokine system.

A Kaufmann1, R Salentin, R G Meyer, D Bussfeld, C Pauligk, H Fesq, P Hofmann, M Nain, D Gemsa, H Sprenger.   

Abstract

Monocytes/macrophages are highly susceptible to an infection with influenza A virus. After infection, de novo virus protein synthesis is detectable but rapidly interrupted before completion of the first viral replication cycle. Within 24-48 hours the infected monocytes die by apoptosis. Before cell death, infected monocytes initiate a cell-specific immune response. This includes the transcription and subsequent release of TNF-alpha (tumor necrosis factor alpha), IL-1beta (Interleukin 1beta), IL-6, type I inferferons and CC chemokines. Enhanced cytokine mRNA expression is due to a prolonged mRNA stability and an augmented gene transcription. Activation of transcription factors such as NF-kappaB (nuclear factor kappaB) and AP-1 are involved in activation of cytokine mRNA transcription. Infection of monocytes with influenza A virus induces the selective expression of mononuclear leukocyte attracting chemokines, such as MCP-1 (monocyte chemotactic protein 1), MIP-1alpha (macrophage inflammatory protein 1alpha) and RANTES (regulated upon activation, normal T cell expressed and secreted). In striking contrast, the release of the neutrophil-specific chemokines IL-8 (interleukin 8) and GRO-alpha (growth stimulatory activity alpha) is entirely suppressed. This differentially regulated chemokine expression may explain the mononuclear cell infiltrate characteristic for virus-infected tissue. Thus, infection of monocytes/macrophages with influenza A virus primes for a rapid proinflammatory reaction and induces an enhanced immigration of mononuclear cells into infected tissue. Taken together, these mechanisms may prepare the infected host for a fast and virus-specific immune response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11846225     DOI: 10.1078/0171-2985-00099

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  26 in total

1.  Live attenuated influenza virus expressing human interleukin-2 reveals increased immunogenic potential in young and aged hosts.

Authors:  Boris Ferko; Christian Kittel; Julia Romanova; Sabine Sereinig; Hermann Katinger; Andrej Egorov
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

2.  1, 8-Cineol Protect Against Influenza-Virus-Induced Pneumonia in Mice.

Authors:  Yun Li; Yanni Lai; Yao Wang; Ni Liu; Fengxue Zhang; Peiping Xu
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

3.  Highly pathogenic avian influenza viruses inhibit effective immune responses of human blood-derived macrophages.

Authors:  Judith Friesenhagen; Yvonne Boergeling; Eike Hrincius; Stephan Ludwig; Johannes Roth; Dorothee Viemann
Journal:  J Leukoc Biol       Date:  2012-03-21       Impact factor: 4.962

Review 4.  Influenza A virus infection kinetics: quantitative data and models.

Authors:  Amber M Smith; Alan S Perelson
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

5.  Contributions of E1A to mouse adenovirus type 1 pathogenesis following intranasal inoculation.

Authors:  Jason B Weinberg; Daniel R Jensen; Lisa E Gralinski; Amy R Lake; Gregory S Stempfle; Katherine R Spindler
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

6.  The migration of T cells in response to influenza virus is altered in neonatal mice.

Authors:  J Louise Lines; Samantha Hoskins; Melissa Hollifield; Linda S Cauley; Beth A Garvy
Journal:  J Immunol       Date:  2010-07-23       Impact factor: 5.422

7.  Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses.

Authors:  Wenqian Tao; Brett L Hurst; Akhilesh Kumar Shakya; Md Jasim Uddin; Rohan S J Ingrole; Mayra Hernandez-Sanabria; Ravi P Arya; Lynn Bimler; Silke Paust; E Bart Tarbet; Harvinder Singh Gill
Journal:  Antiviral Res       Date:  2017-02-02       Impact factor: 5.970

8.  An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence.

Authors:  Michael Berger; Philippe Krebs; Karine Crozat; Xiaohong Li; Ben A Croker; Owen M Siggs; Daniel Popkin; Xin Du; Brian R Lawson; Argyrios N Theofilopoulos; Yu Xia; Kevin Khovananth; Eva Marie Moresco; Takashi Satoh; Osamu Takeuchi; Shizuo Akira; Bruce Beutler
Journal:  Nat Immunol       Date:  2010-02-28       Impact factor: 25.606

9.  Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 Virus-like particles.

Authors:  Alfonso García-Piñeres; Allan Hildesheim; Lori Dodd; Troy J Kemp; Marcus Williams; Clayton Harro; Douglas R Lowy; John T Schiller; Ligia A Pinto
Journal:  Clin Vaccine Immunol       Date:  2007-06-27

10.  The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells.

Authors:  Celeste M Newby; Leah Sabin; Andrew Pekosz
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.